Careers
Contact
Company
About Us
People
Scientific Founders
Leadership Team
Board of Directors
Scientific Advisory Board
Key Advisors
Investors
Careers
Open Positions
Contact
Technology
Technology Overview
iPS
Cell Technology
Differentiation
Proof of Concept
Advancing Cellular Programming
Scientific Advantages
Phenotypic Assay Development
Therapeutic Areas
Therapeutic Areas Overview
Neurological Diseases
Cardiovascular Disease
Metabolic Diseases
Collaborators
Collaborators Overview
News & Events
Newsroom
In the News
Press Releases
2010
2009
2008
Media Kit
Events
Newsroom
In the News
Press Releases
2010
2009
2008
Media Kit
Events
"We are dedicated to making iPSC technology the industry standard for the early introduction of human pharmacology into the drug discovery process."
-Michael C. Venuti, Ph.D., CEO, iPierian
Media Kit
Print
Email
Scientific Advisory Board Article
iPierian Fact Sheet